Literature DB >> 34625741

Apolipoproteins in vascular biology and atherosclerotic disease.

Anurag Mehta1, Michael D Shapiro2.   

Abstract

Apolipoproteins are important structural components of plasma lipoproteins that influence vascular biology and atherosclerotic disease pathophysiology by regulating lipoprotein metabolism. Clinically important apolipoproteins related to lipid metabolism and atherogenesis include apolipoprotein B-100, apolipoprotein B-48, apolipoprotein A-I, apolipoprotein C-II, apolipoprotein C-III, apolipoprotein E and apolipoprotein(a). Apolipoprotein B-100 is the major structural component of VLDL, IDL, LDL and lipoprotein(a). Apolipoprotein B-48 is a truncated isoform of apolipoprotein B-100 that forms the backbone of chylomicrons. Apolipoprotein A-I provides the scaffolding for lipidation of HDL and has an important role in reverse cholesterol transport. Apolipoproteins C-II, apolipoprotein C-III and apolipoprotein E are involved in triglyceride-rich lipoprotein metabolism. Apolipoprotein(a) covalently binds to apolipoprotein B-100 to form lipoprotein(a). In this Review, we discuss the mechanisms by which these apolipoproteins regulate lipoprotein metabolism and thereby influence vascular biology and atherosclerotic disease. Advances in the understanding of apolipoprotein biology and their translation into therapeutic agents to reduce the risk of cardiovascular disease are also highlighted.
© 2021. Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34625741     DOI: 10.1038/s41569-021-00613-5

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


  130 in total

Review 1.  Complexity in the secretory pathway: the assembly and secretion of apolipoprotein B-containing lipoproteins.

Authors:  Edward A Fisher; Henry N Ginsberg
Journal:  J Biol Chem       Date:  2002-03-21       Impact factor: 5.157

Review 2.  Lipoprotein lipase: structure, function, regulation, and role in disease.

Authors:  James R Mead; Scott A Irvine; Dipak P Ramji
Journal:  J Mol Med (Berl)       Date:  2002-10-24       Impact factor: 4.599

Review 3.  Intracellular degradation of newly synthesized apolipoprotein B.

Authors:  Z Yao; K Tran; R S McLeod
Journal:  J Lipid Res       Date:  1997-10       Impact factor: 5.922

Review 4.  Structure of apolipoprotein B-100 in low density lipoproteins.

Authors:  J P Segrest; M K Jones; H De Loof; N Dashti
Journal:  J Lipid Res       Date:  2001-09       Impact factor: 5.922

Review 5.  Apolipoproteins: metabolic role and clinical biochemistry applications.

Authors:  Marek H Dominiczak; Muriel J Caslake
Journal:  Ann Clin Biochem       Date:  2011-10-25       Impact factor: 2.057

Review 6.  The assembly and secretion of apolipoprotein B-containing lipoproteins.

Authors:  S O Olofsson; L Asp; J Borén
Journal:  Curr Opin Lipidol       Date:  1999-08       Impact factor: 4.776

7.  Apolipoprotein B100 exit from the endoplasmic reticulum (ER) is COPII-dependent, and its lipidation to very low density lipoprotein occurs post-ER.

Authors:  Viktoria Gusarova; Jeffrey L Brodsky; Edward A Fisher
Journal:  J Biol Chem       Date:  2003-09-05       Impact factor: 5.157

Review 8.  Plasma lipoproteins: apolipoprotein structure and function.

Authors:  R W Mahley; T L Innerarity; S C Rall; K H Weisgraber
Journal:  J Lipid Res       Date:  1984-12-01       Impact factor: 5.922

9.  Presecretory oxidation, aggregation, and autophagic destruction of apoprotein-B: a pathway for late-stage quality control.

Authors:  Meihui Pan; Vatsala Maitin; Sajesh Parathath; Ursula Andreo; Sharron X Lin; Carly St Germain; Zemin Yao; Frederick R Maxfield; Kevin Jon Williams; Edward A Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-07       Impact factor: 11.205

Review 10.  Recent progress in understanding apolipoprotein B.

Authors:  S G Young
Journal:  Circulation       Date:  1990-11       Impact factor: 29.690

View more
  5 in total

Review 1.  The Roles of Fatty Acids and Apolipoproteins in the Kidneys.

Authors:  Xiaoyue Pan
Journal:  Metabolites       Date:  2022-05-20

2.  Molecular Genetics and Cytotoxic Responses to Titanium Diboride and Zinc Borate Nanoparticles on Cultured Human Primary Alveolar Epithelial Cells.

Authors:  Hasan Türkez; Mehmet Enes Arslan; Arzu Tatar; Özlem Özdemir; Erdal Sönmez; Kenan Çadirci; Ahmet Hacimüftüoğlu; Bahattin Ceylan; Metin Açikyildiz; Cigdem Yuce Kahraman; Fatime Geyikoğlu; Abdulgani Tatar; Adil Mardinoglu
Journal:  Materials (Basel)       Date:  2022-03-22       Impact factor: 3.623

Review 3.  New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins.

Authors:  Kyuho Kim; Henry N Ginsberg; Sung Hee Choi
Journal:  Diabetes Metab J       Date:  2022-07-27       Impact factor: 5.893

Review 4.  There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: A review of current practice and recommendations for improved effectiveness.

Authors:  Michael E Makover; Michael D Shapiro; Peter P Toth
Journal:  Am J Prev Cardiol       Date:  2022-08-06

Review 5.  Low-density lipoprotein particles in atherosclerosis.

Authors:  Ya-Nan Qiao; Yan-Li Zou; Shou-Dong Guo
Journal:  Front Physiol       Date:  2022-08-30       Impact factor: 4.755

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.